Make Training Great Again: Maximize Your Innovation Investment with a Tailored Training Plan
We all know how important training is in the workplace; our new starters can’t get to work without i...
A Winning Methodology: Key Criteria for Success in Launching an NGS assay
Consider this: your company has decided to bring on a new next-generation sequencing (NGS) assay, an...
A Story of Support: Our Innovation Improves Your Results
Whether you’re a clinician or a researcher, you’ve likely been in a situation where you’re waiting o...
STAARpipeline apps: Enhancing Rare Variant Analysis in Whole-Genome Sequencing Studies
Overview of STAARpipeline apps
Level Up your Documentation Processes and Systems to Comply with FDA Final Rule Stages 1 & 2
FDA’s ruling on enforcement of in vitro diagnostic (IVD) medical device requirements for laboratory-...
Enhancing the Precision Medicine Journey
Five Focus Areas for Our Chief Customer Officer
Get Ready to Comply with FDA Final Rule Stages 1 & 2: Yeah, We Mean You
FDA's New LDT Rule: An Overview
Navigating your molecular lab’s test selection and development over the next two years
With the FDA’s publication of the final rule on laboratory developed tests (LDTs) on May 6, 2024, cl...